Low-dose oral minoxidil for persistent chemotherapy and radiotherapy-induced alopecia in a pediatric female patient

April 2024 in “ Anais Brasileiros de Dermatologia ”

Raíssa Rodriguez Melo, Rita Fernanda Cortez de Almeida, Luciana Rodino Lemes, Sidney Frattini, Paulo Müller Ramos, Daniel Fernandes Melo

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on sciencedirect.com →

Discuss this study in the Community →

Research cited in this study

4 / 4 results

research Systemic Minoxidil for Hair Disorders in Pediatric Patients: A Safety and Tolerability Review

August 2022 in “International Journal of Dermatology”

Low-dose oral and sublingual minoxidil seem safe for children with hair disorders.

research Permanent Chemotherapy-Induced Alopecia After Hematopoietic Stem Cell Transplantation Treated With Low-Dose Oral Minoxidil

4 citations , February 2022 in “JAAD case reports”

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors

research Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors

10 citations , September 2021 in “JAMA Dermatology”

Different types of persistent hair loss after chemotherapy respond differently to treatments.

research Hair Disorders in Patients with Cancer

53 citations , April 2018 in “Journal of The American Academy of Dermatology”

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.